Addendum
Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy –Third addendum to Commission E16-03
Report documents
-
Extract of the addendum
Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy –Third addendum to Commission E16-03
-
Addendum
Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy –Third addendum to Commission E16-03
Project details
- Project no.
- E23-07
- Commission
- Commission awarded on 24.08.2023 by the Federal Joint Committee (GBA).
- Report type
- Addendum
- Status
- Commission completed
- Department/Division
- Non-Drug Interventions
- Topic
- Head and nerves
- Note
-
Within the framework of the testing regulation (German version) the Federal Joint Committee (GBA) can commission IQWiG to assess the potential of a new examination or treatment method (i.e. of a medical device). As part of an administrative procedure conducted by the GBA, the topics and content of the assessments of the potential of medical devices are partly or temporarily confidential.
- DOI
https://doi.org/10.60584/E23-07
Connected Projects
-
Assessment of potential
Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy
Status: Commission completed